Nov 16 (Reuters) - Zhejiang Hisoar Pharmaceutical
Post# of 36537
(Total Views: 473)
Posted On: 11/16/2020 9:00:40 AM
Nov 16 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd :
* SAYS ITS INDUSTRY FUND IS PARTICIPATING IN VACCINE DEVELOPMENT PROJECT WITH PARTNERS INCLUDING GENEREX BIOTECHNOLOGY
* SAYS PARTNERS ALSO INCLUDE CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION
* SAYS THE VACCINE PROJECT IS STILL AT PRE-CLINICAL STAGE Source text in Chinese: https://bit.ly/3lBKucl Further company coverage: (Reporting by Hong Kong newsroom)
* SAYS ITS INDUSTRY FUND IS PARTICIPATING IN VACCINE DEVELOPMENT PROJECT WITH PARTNERS INCLUDING GENEREX BIOTECHNOLOGY
* SAYS PARTNERS ALSO INCLUDE CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION
* SAYS THE VACCINE PROJECT IS STILL AT PRE-CLINICAL STAGE Source text in Chinese: https://bit.ly/3lBKucl Further company coverage: (Reporting by Hong Kong newsroom)
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼